We examined sequencing data from publicly available datasets and published literature, and identified an additional 75 tumor samples and two thyroid cancer cell lines with KEAP1 mutations (Figure 1, Supplementary Table S2). This evidence concerns the gene KEAP1 and thyroid cancer.